16 States Keen On Developing Medical Devices Parks

Hyderabad : The Union government is scrutinising applications received from 16 States that showed interest in promoting medical devices parks, according to S Eswara Reddy, Joint Drugs Controller at the Central Drugs Standard Control Organisation. Addressing a session on ‘Medical Technologies – the next big opportunity for India’ at the BioAsia-2021 on Tuesday, he said the government had introduced an incentive-based scheme to encourage indigenous production of medical devices. The Government has already cleared a few categories of medical devices under the PLI (Production Linked Incentive) scheme. The salient feature of the scheme is that the government will provide 5 per cent incentive on incremental sales of devices manufactured in the country,” he said.

Telangana IT and Industries Secretary Jayesh Ranjan said the State Government had visualised the importance of promoting manufacturing of medical devices. “We established a 250-acre medical devices park at Sultanpur in 2017. We studied the China model and found that they focussed on backward integration and research and development ecosystem,” he said.

“Hyderabad is doing exceedingly well in vaccines, biotech, research and development and bulk drugs. Identifying the need for medical devices manufacturing, we set up the park,” he said.

Over 40 companies have signed up for setting up units in the park, he said.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad